Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies

No abstract is available for this paper.

• Publication year

  2015

• Venue

  British Journal of Nutrition

• Publication date

  2015-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1017/S000711451500183XPMID 26173770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk

  2014cited by this paper
• Cholesterol and Cancer, in the Balance

  2014cited by this paper
• The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses

  2014cited by this paper
• Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies.

  2013cited by this paper
• Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties

  2013cited by this paper
• Serum Lipid Profiles and Cancer Risk in the Context of Obesity: Four Meta-Analyses

  2013cited by this paper
• Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis

  2013cited by this paper
• Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies.

  2012cited by this paper
• HDL functionality

  2012cited by this paper
• Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software.

  2012cited by this paper
• Cardiometabolic factors and breast cancer risk in U.S. black women

  2012cited by this paper
• Lipid Profiles and Risk of Breast and Ovarian Cancer in the Swedish AMORIS Study

  2012influential reference
• Metabolic syndrome and incidence of liver and breast cancers in Japan.

  2012cited by this paper
• The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

  2012cited by this paper
• Total cholesterol and cancer risk in a large prospective study in Korea.

  2011cited by this paper
• Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.

  2011cited by this paper
• Total Serum Cholesterol and Cancer Incidence in the Metabolic Syndrome and Cancer Project (Me-Can)

  2011cited by this paper
• Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer: results from the prospective E3N cohort

  2010influential reference
• Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma

  2010cited by this paper
• Metabolic Syndrome and Breast Cancer in the Me-Can (Metabolic Syndrome and Cancer) Project

  2010cited by this paper
• Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study.

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan

  2009cited by this paper
• Serum cholesterol levels in relation to the incidence of cancer: The JPHC study cohorts

  2009cited by this paper
• Cholesterol and Cancer: Answers and New Questions

  2009cited by this paper
• A Longitudinal Study of the Metabolic Syndrome and Risk of Postmenopausal Breast Cancer

  2009cited by this paper
• Sex differences in hepatic regulation of cholesterol homeostasis.

  2008cited by this paper
• Meta-Regression in Stata

  2008influential reference
• HDL-cholesterol and incidence of breast cancer in the ARIC cohort study.

  2008influential reference
• Metan: Fixed- and Random-Effects Meta-Analysis

  2008cited by this paper
• Influence of Aging and Menopause on Lipids and Lipoproteins in Women

  2008cited by this paper
• How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis?

  2008cited by this paper
• Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts

  2006cited by this paper
• Dyslipidemia and inflammation: an evolutionary conserved mechanism.

  2005cited by this paper
• Current understanding of the metabolism and biological actions of HDL

  2005influential reference
• Serum lipids, lipid-lowering drugs, and the risk of breast cancer.

  2005influential reference
• Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

  2004cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials.

  2002cited by this paper
• Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmö Preventive Project

  2001cited by this paper
• Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status.

  1998influential reference
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders.

  1997cited by this paper
• Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity.

  1995cited by this paper
• Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women

  1994influential reference
• Operating characteristics of a rank correlation test for publication bias.

  1994cited by this paper
• Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women

  1992cited by this paper
• Methods for trend estimation from summarized dose-response data, with applications to meta-analysis.

  1992cited by this paper
• Altered pattern of lipid metabolism in patients with lung cancer.

  1992cited by this paper
• Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies

  1991cited by this paper
• Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women.

  1990influential reference
• Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate.

  1989cited by this paper
• Serum cholesterol and risk of cancer in a cohort of 39,000 men and women.

  1988cited by this paper
• Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure.

  1988influential reference
• Serum cholesterol and the incidence of cancer in a large cohort.

  1986cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia.

  1985cited by this paper
• Breast cancer and serum cholesterol.

  1982cited by this paper
• Letter: Preparation for colonic surgery.

  1975cited by this paper

• Dietary restriction genes as modulators of breast cancer risk through metabolic pathways.

  2026cites this paper
• Reopening Pandora's box: is there a role for HDL in breast cancer?

  2025cites this paper
• Blood Lipidomic And Breast Cancer Risk: Protocol of A Systematic Review

  2025cites this paper
• Causal relationships between four types of lipids and breast cancer risk with potential mediators: evidence from Mendelian randomization study and bioinformatics analysis

  2025influential citation
• Associations Between Lipid Traits and Breast Cancer Risk: A Mendelian Randomization Study in African Women

  2025cites this paper
• Risk factors for breast cancer: an umbrella review of observational cohort studies and causal relationship analysis

  2025cites this paper
• A cross-sectional study of serum lipids, body mass index and age relationships with breast cancer risk

  2025cites this paper
• Genetic association of lipids and lipid-lowering drug target genes with breast cancer

  2025cites this paper
• Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment

  2025cites this paper
• Multilayer analysis of ethnically diverse blood and urine biomarkers for breast cancer risk and prognosis

  2025cites this paper
• Biological embodiment of educational attainment and future risk of breast cancer: findings from a French prospective cohort

  2025influential citation
• Predicting doxorubicin-induced cardiotoxicity in breast cancer: leveraging machine learning with synthetic data

  2025cites this paper
• Role of a Whole Plant Foods Diet in Breast Cancer Prevention and Survival.

  2025cites this paper
• Molecular detection of GSTM and GSTT genes with biomarkers studies in samples of Iraqi breast cancer patients

  2025cites this paper
• Lipid Metabolism in Breast Cancer: From Basic Research to Clinical Application

  2025cites this paper
• Role of protein regulators of cholesterol homeostasis in immune modulation and cancer pathophysiology.

  2025cites this paper
• Postmenopausal Obesity and Dyslipidemia as Risk Factors for Breast Cancer in Korean Women: Analysis of a National Health Screening Cohort

  2025cites this paper
• Fibroblast growth factor receptor signaling modulates cholesterol storage in a SOAT1-dependent manner to promote mammary tumor cell invasion

  2025cites this paper
• Adherence to a Cholesterol‐Lowering Diet and the Risk of Female Hormone‐Related Cancers: An Analysis From a Case–Control Study Network

  2025cites this paper
• Causes and Risk Factors of Breast Cancer, What Do We Know for Sure? An Evidence Synthesis of Systematic Reviews and Meta-Analyses

  2024cites this paper
• The Causal Association Between Blood Lipids and Breast Cancer in African Women: A Mendelian Randomization study

  2024cites this paper
• Impact of serum lipid on recurrence of uterine fibroids: a single center retrospective study

  2024cites this paper
• Genetically Proxied Therapeutic Effect of Lipid-Lowering Drugs Use, Breast Cancer, and Endometrial Cancer’s Risk: A Drug Target-Based Mendelian Randomization Study

  2024cites this paper
• Breast cancer and its determinants in Ethiopia: a systematic review and meta-analysis

  2024cites this paper
• Association between remnant cholesterol and the risk of 4 site-specific cancers: evidence from a cross-sectional and Mendelian randomization study

  2024cites this paper
• Non-genetic factors and breast cancer: an umbrella review of meta-analyses

  2024cites this paper
• Association between serum total cholesterol and the development of gastric cancer: A two-way two-sample Mendelian randomization study

  2024cites this paper
• The Importance of Metabolic Factors in Endometrial Cancer: Evaluating the Utility of the Triglyceride-to-Glycemia Index and Triglyceride-to-High-Density Lipoprotein Ratio As Biomarkers

  2024cites this paper
• Lipid Profile and Atherogenic Risk Assessment in Nigerian Breast Cancer Patients - A Cross-Sectional Study.

  2024cites this paper
• An analysis of the association between breast density and body mass index with breast cancer molecular subtypes in early breast cancer: data from a Spanish population

  2024influential citation
• Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study

  2024cites this paper
• A population-based cohort study of longitudinal change of high-density lipoprotein cholesterol impact on gastrointestinal cancer risk

  2024cites this paper
• Is STARD3 A New Biomarker for Breast Cancer?

  2024cites this paper
• Circulating lipids, lipid-lowering drug targets, and breast cancer risk: Comprehensive evidence from Mendelian randomization and summary data-based Mendelian randomization

  2024cites this paper
• A Plant-Based Cholesterol-Lowering Diet Score Correlates with Serum LDL-Cholesterol Levels

  2024cites this paper
• Impact of De Novo Cholesterol Biosynthesis on the Initiation and Progression of Breast Cancer

  2024cites this paper
• Association between total cholesterol levels and all-cause mortality among newly diagnosed patients with cancer

  2024cites this paper
• High-density lipoprotein cholesterol and carcinogenesis.

  2023cites this paper
• Visualization and Quantification of the Association Between Breast Cancer and Cholesterol in the All of Us Research Program

  2023cites this paper
• Circulating levels of biomarkers and risk of ductal carcinoma in situ of the breast in the UK Biobank study

  2023influential citation
• Lifestyle Factors and Energy Intakes with Risks of Breast Cancer among Pre- and Post- Menopausal Women in Taiwan

  2023cites this paper
• Mendelian randomization analysis revealed potential metabolic causal factors for breast cancer

  2023cites this paper
• Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes Mellitus

  2023cites this paper
• The clinical application of atorvastatin in patients with small-cell lung cancer with dyslipidemia

  2023cites this paper
• Association of serum lipids and abnormal lipid score with cancer risk: a population-based prospective study

  2023cites this paper
• Is cholesterol a risk factor for breast cancer incidence and outcome?

  2023cites this paper
• Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies.

  2023cites this paper
• Mitochondrial Metabolism Drives Low-density Lipoprotein-induced Breast Cancer Cell Migration

  2023cites this paper
• Cholesterol and breast cancer risk: a cohort study using health insurance claims and health checkup databases

  2023cites this paper
• The emerging role of 27-hydroxycholesterol in cancer development and progression: An update.

  2022cites this paper
• Association of lipid profile biomarkers with breast cancer by molecular subtype: analysis of the MEND study

  2022cites this paper
• Systematic review of Mendelian randomization studies on risk of cancer

  2022influential citation
• Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers

  2022cites this paper
• Possible role of lead in breast cancer — a case-control study

  2022cites this paper
• Association of SNP rs5069 in APOA1 with Benign Breast Diseases in a Mexican Population

  2022cites this paper
• Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression

  2022cites this paper
• The mevalonate pathway in breast cancer biology.

  2022cites this paper
• DriverMP enables improved identification of cancer driver genes

  2022cites this paper
• Cardiovascular risk factors and breast cancer incidence in a large middle-aged cohort study

  2022cites this paper
• An Updated Systematic Review and Meta-Analysis on Association of Serum Lipid Profile With Risk of Breast Cancer Incidence

  2022influential citation
• Correlations between serum lipid and Ki-67 levels in different breast cancer molecular subcategories

  2022cites this paper
• Serum cholesterol and the risk of developing hormonally driven cancers: A narrative review

  2022cites this paper
• Lipid-Based Factors: A Promising New Biomarker for Predicting Prognosis and Conditional Survival Probability in Hepatocellular Carcinoma

  2022cites this paper
• changes of serum irisin levels in postmenopausal breast cancer women

  2022cites this paper
• Roles of ABCA1 in cancer.

  2022cites this paper
• The association between serum lipid levels and histological type of breast cancer

  2022cites this paper
• Association of time of breakfast and nighttime fasting duration with breast cancer risk in the multicase-control study in Spain

  2022cites this paper
• Effect of Serum Lipid Profile on the Risk of Breast Cancer: Systematic Review and Meta-Analysis of 1,628,871 Women

  2022cites this paper
• Association of lipid profile with obesity among breast cancer survivors: a cross-sectional study

  2022cites this paper
• Integrating Mendelian randomization and literature-mined evidence for breast cancer risk factors

  2022cites this paper
• Disparities in Metabolic Conditions and Cancer Characteristics among Hispanic Women with Breast Cancer: A Multi-Institutional Study

  2022cites this paper
• High density lipoproteins and oxidative stress in breast cancer

  2021cites this paper
• Obesity, Type 2 Diabetes, and Cancer Risk

  2021cites this paper
• Association of Lipid Profile Biomarkers with Breast Cancer by Molecular Subtype: analysis of the Mechanisms for Established and Novel Risk Factors for Breast Cancer in Women of African Descent (MEND) study

  2021cites this paper
• Targeting HDL in tumor microenvironment: New hope for cancer therapy

  2021cites this paper
• Relationship between body mass index and cholesterol levels with histopathological grading of breast cancer.

  2021cites this paper
• PCSK9 and cancer: Rethinking the link.

  2021cites this paper
• Impact of cholesterol-pathways on breast cancer development, a metabolic landscape

  2021cites this paper
• The significances and clinical implications of cholesterol components in human breast cancer

  2021cites this paper
• STARD3: A Prospective Target for Cancer Therapy

  2021cites this paper
• Investigation of the Interplay between Circulating Lipids and IGF-I and Relevance to Breast Cancer Risk: An Observational and Mendelian Randomization Study

  2021cites this paper
• An impact of lipid profile and lipid lowering drugs on ≥70 year olds of an upper socioeconomic class: a retrospective cohort study

  2021cites this paper
• Cardiovascular status of breast cancer patients before and after receiving anthracycline chemotherapy regimen

  2021cites this paper
• Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan

  2021cites this paper
• Association between serum lipids and breast cancer risk in premenopausal women: systematic review and meta-analysis

  2021cites this paper
• Time-Restricted Eating: A Novel and Simple Dietary Intervention for Primary and Secondary Prevention of Breast Cancer and Cardiovascular Disease

  2021cites this paper
• A Comprehensive Review on PCSK9 as Mechanistic Target Approach in Cancer Therapy.

  2021cites this paper
• Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

  2021cites this paper
• The link between mammary cancer, excessive adipose tissue and cholesterol

  2021cites this paper
• Lipidomic Analysis of Cells and Extracellular Vesicles from High- and Low-Metastatic Triple-Negative Breast Cancer

  2020cites this paper
• Cholesterol metabolism pathways – are the intermediates more important than the products?

  2020cites this paper
• LIPID PROFILE AND ITS SIGNIFICANCE IN BREAST CANCER

  2020cites this paper
• LDL, HDL and endocrine-related cancer: from pathogenic mechanisms to therapies.

  2020cites this paper
• High Serum Levels of Cholesterol Increase Anti-tumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.

  2020cites this paper
• Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals

  2020cites this paper
• Role of cholesterol metabolism in the anticancer pharmacology of selective estrogen receptor modulators.

  2020cites this paper
• The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study

  2020cites this paper
• Assessment of YKL-40, lipid profile, antioxidant status, and some trace elements in benign and malignant breast proliferation

  2020cites this paper
• Physiological and histopathological alterations in male Swiss mice after exposure to titanium dioxide (anatase) and zinc oxide nanoparticles and their binary mixture

  2020cites this paper
• The 5,6‐epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets

  2020cites this paper